Key Highlights
- RKLB shares have declined approximately 30% from late-May highs, currently hovering near $107.98
- First quarter revenue reached an all-time high of $200.35 million, representing 63.4% year-over-year growth and surpassing analyst forecasts
- The company will be added to the Nasdaq-100 index on June 22, potentially driving increased institutional investment
- Institutional investors now hold 71.78% of shares, with Capital Impact Advisors increasing its position by 47.5%
- Analyst consensus points to a “Moderate Buy” with an average target price of $102.76
Shares of Rocket Lab have experienced significant downward pressure following SpaceX’s high-profile IPO announcement, with RKLB tumbling nearly 30% from its late-May peak of approximately $151.00. Trading commenced Thursday at $107.98, maintaining support above the 50-day moving average of $104.00 while remaining substantially below recent peaks.
The share price decline contrasts sharply with operational performance. First quarter revenue reached $200.35 million, establishing a new quarterly record and representing a robust 63.4% increase compared to the prior year period. This figure exceeded Wall Street’s consensus estimate of $189.65 million.
Gross profit margins also achieved a company record of 38.2% during Q1, demonstrating enhanced operational efficiency as the business expands. The company’s backlog has grown to $2.2 billion, providing substantial revenue visibility for upcoming quarters.
Executive guidance points toward another record-breaking quarter in Q2, maintaining a growth trajectory that indicates Rocket Lab is experiencing sustainable expansion rather than temporary momentum.
Government Defense Contracts Expand Revenue Streams
Rocket Lab is strategically diversifying beyond its core launch business through significant defense sector contracts. In 2024, the company won a substantial $515 million contract from the Space Development Agency to manufacture satellites, establishing its position as a primary contractor for U.S. government programs.
Additionally, the firm secured a $30 million agreement with Anduril Industries for hypersonic test launches utilizing its HASTE platform from Virginia’s Launch Complex 2. These government partnerships are expanding the company’s revenue portfolio beyond traditional commercial small-satellite launch services.
Rocket Lab’s Electron launch vehicle maintains its position as the most frequently deployed small rocket globally, conducting 10–15 missions annually. Its primary competitor in this market segment is Galactic Energy’s Ceres-1 platform.
In a significant commercial development last month, the company announced its largest block-purchase agreement to date — five Neutron rocket launches booked before the vehicle’s maiden flight.
Index Addition and Growing Institutional Positions
Rocket Lab’s upcoming addition to the Nasdaq-100 on June 22 represents a potentially significant catalyst. Index inclusion historically triggers substantial buying activity from passive investment funds required to track the benchmark.
Capital Impact Advisors expanded its holdings by 47.5% during the fourth quarter, purchasing an additional 145,741 shares to reach a total position of 452,728 shares. Institutional investors collectively control 71.78% of outstanding shares.
Regarding insider activity, SVP Arjun Kampani divested 23,804 shares at $147.43 on May 28, while insider Marvin Bradford Clevenger sold 3,500 shares at $146.67 the same day. Company insiders have collectively sold $66.9 million in stock over the trailing 90-day period.
Valuation metrics present challenges for investors. RKLB currently trades at a forward price-to-sales ratio near 68x, exceeding the sector median by more than 3,500%. Such elevated multiples are generally associated with high-margin software companies rather than hardware manufacturers operating at 38% gross margins.
Neutron, the medium-lift launch vehicle upon which much of the current valuation appears predicated, has not yet conducted its inaugural flight. A propellant tank testing setback has delayed the first launch until Q4 2026, maintaining execution uncertainty.
TD Cowen and Needham both elevated their price targets to $120 with Buy recommendations following the Q1 earnings release. KGI Securities commenced coverage on June 11 with a Neutral rating and $105 price target. The Wall Street consensus target currently stands at $102.76.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
